How are RNA vaccines tested?
7 answers found
As new cancer antigens come to the forefront with novel RNA encapsulation and targeting techniques, RNA vaccines may prove to be a vital, safe and robust method to initiate patient-specific anti-tumor efficacy.
Given the many positive attributes of nucleic acid vaccines, our results suggest that a comprehensive evaluation of nonviral technologies to deliver self-amplifying RNA vaccines is warranted.
This suggests that protein-based vaccines formulated using RNA adjuvant function as live-attenuated vaccines.
Therefore, RNA adjuvants have broad applicability and can be used with all conventional vaccines to improve vaccine efficacy qualitatively and quantitively.
Our findings imply that bioavailability of recombinant RNA vaccines in vivo highly depends on the density and the maturation stage of DCs at the administration site and are of importance for the design of RNA-based clinical immunotherapy protocols.
The possible utility of RNA‐based vaccines for tumor immunotherapy should be further explored to determine whether such approaches are clinically useful.
RNA as a tumor vaccine: a review of the literature
01 Jun 2001•Experimental Dermatology 82 citations
Notably, our data demonstrate that mRNA vaccines can compete with licensed vaccines based on inactivated virus or are even superior in respect of functional antibody and T cell responses.
Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines.
19 Oct 2017• 96 citations
Are all vaccines RNA?8 answers
Are RNA vaccines inactivated?8 answers
Is there RNA in other vaccines?9 answers
What other vaccines have used RNA?9 answers
Do RNA vaccines exist?8 answers
Are there other vaccines that use RNA?10 answers
Are RNA vaccines really Vaccines?9 answers
How long have we used RNA vaccines?8 answers